0,965  0,003  12-Lipoxygenase inhibitor
0,951  0,003  Lipoxygenase inhibitor
0,945  0,002  Monophenol monooxygenase inhibitor
0,927  0,003  15-Lipoxygenase inhibitor
0,911  0,001  Melanin inhibitor
0,906  0,003  CYP1A2 inhibitor
0,904  0,002  NOS2 expression inhibitor
0,856  0,003  AR expression inhibitor
0,853  0,004  Aryl hydrocarbon receptor agonist
0,851  0,005  Caspase 9 stimulant
0,839  0,002  UGT1A3 substrate
0,836  0,004  CYP2C19 substrate
0,842  0,012  Apoptosis agonist
0,839  0,010  Transcription factor NF kappa B inhibitor
0,829  0,003  UGT1A9 substrate
0,824  0,002  UGT1A1 substrate
0,823  0,004  Chemopreventive
0,808  0,004  CTGF expression inhibitor
0,806  0,005  Chemoprotective
0,802  0,005  Radioprotector
0,794  0,004  Antioxidant
0,805  0,017  Alpha-glucosidase inhibitor
0,781  0,005  Aldehyde oxidase inhibitor
0,777  0,004  Antimutagenic
0,754  0,004  MAO inhibitor
0,752  0,005  Caspase 3 stimulant
0,750  0,004  Skin whitener
0,738  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,732  0,006  Cytostatic
0,738  0,015  Antineoplastic (breast cancer)
0,726  0,005  Free radical scavenger
0,723  0,004  CYP2C19 inhibitor
0,728  0,015  Antineoplastic (lung cancer)
0,712  0,008  CYP1A2 substrate
0,700  0,005  UGT1A6 substrate
0,701  0,010  Antihypercholesterolemic
0,689  0,007  Proliferative diseases treatment
0,684  0,004  MAO A inhibitor
0,682  0,008  CYP2D6 substrate
0,693  0,032  Antiinflammatory
0,663  0,006  CYP2C9 inhibitor
0,649  0,004  NOS3 expression enhancer
0,650  0,006  Antineoplastic (glioma)
0,647  0,004  Amylase inhibitor
0,654  0,018  Antineoplastic (colorectal cancer)
0,650  0,018  Antineoplastic (colon cancer)
0,634  0,008  Cardioprotectant
0,622  0,009  Antiosteoporotic
0,624  0,012  Bone diseases treatment
0,625  0,016  Carcinogenic
0,620  0,011  Antineoplastic (melanoma)
0,612  0,004  Breast cancer-resistant protein inhibitor
0,622  0,019  CYP2C9 substrate
0,617  0,016  Prostate cancer treatment
0,606  0,010  NOS3 expression inhibitor
0,613  0,022  Antileukemic
0,594  0,004  MAO B inhibitor
0,586  0,005  Antihypoxic
0,578  0,003  Beta glucuronidase inhibitor
0,576  0,012  Apoptosis antagonist
0,571  0,008  UDP-glucuronosyltransferase substrate
0,572  0,011  Nitric oxide antagonist
0,569  0,012  Antineoplastic (brain cancer)
0,561  0,010  Amyloid beta aggregation inhibitor
0,573  0,030  TNF expression inhibitor
0,551  0,017  Antineoplastic (cervical cancer)
0,535  0,005  Sulfotransferase substrate
0,547  0,018  Mutagenic
0,531  0,006  Genotoxic
0,526  0,005  Antihypotensive
0,546  0,029  Antibacterial
0,524  0,009  Antihypertriglyceridemic
0,531  0,020  Histamine release inhibitor
0,522  0,010  Antineoplastic (osteosarcoma)
0,511  0,009  UGT2B4 substrate
0,512  0,013  Antineoplastic (glioblastoma multiforme)
0,503  0,005  Lipid peroxidase inhibitor
0,518  0,021  Spasmolytic
0,518  0,021  Sensitization
0,510  0,015  Antiamyloidogenic
0,503  0,026  Antineoplastic (ovarian cancer)
0,479  0,004  Xanthine oxidase inhibitor
0,491  0,018  Antineoplastic (non-small cell lung cancer)
0,473  0,002  Papain-like protease (SARS coronavirus) inhibitor
0,477  0,017  Hypoglycemic
0,478  0,019  Antiprotozoal (Leishmania)
0,469  0,014  Vascular (periferal) disease treatment
0,471  0,016  Superoxide dismutase inhibitor
0,478  0,024  Antineoplastic (pancreatic cancer)
0,457  0,005  UGT2B15 substrate
0,458  0,006  VCAM1 expression inhibitor
0,451  0,006  Protein-tyrosine phosphatase inhibitor
0,448  0,004  Heat shock protein 90 antagonist
0,445  0,004  Antibacterial (Helicobacter pylori)
0,451  0,015  Antineoplastic (renal cancer)
0,439  0,004  Estrogen receptor alpha antagonist
0,443  0,008  Bone formation stimulant
0,450  0,016  Vasodilator
0,438  0,012  UGT1A4 substrate
0,435  0,009  Topoisomerase II inhibitor
0,437  0,013  P-glycoprotein inhibitor
0,426  0,011  Hepatoprotectant
0,417  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,437  0,026  Antineoplastic (multiple myeloma)
0,443  0,032  Hepatic disorders treatment
0,435  0,027  ICAM1 expression inhibitor
0,446  0,039  Ulceration
0,454  0,054  Antiparkinsonian
0,403  0,005  CYP2B6 inhibitor
0,402  0,005  5-Lipoxygenase inhibitor
0,417  0,030  Vasodilator, coronary
0,439  0,053  CYP3A4 substrate
0,388  0,012  Mcl-1 antagonist
0,400  0,028  Antiprotozoal (Trypanosoma)
0,402  0,031  CYP3A4 inhibitor
0,376  0,006  Alkaline phosphatase inhibitor
0,372  0,005  Neurotrophic factor
0,370  0,007  Heat shock protein 90 alpha antagonist
0,365  0,005  Antihemorrhagic
0,403  0,044  Respiratory analeptic
0,363  0,005  Topoisomerase II alpha inhibitor
0,374  0,021  RNA-directed DNA polymerase inhibitor
0,380  0,027  Antiparasitic
0,358  0,007  Aldehyde dehydrogenase inhibitor
0,362  0,014  Antineoplastic (squamous cell carcinoma)
0,374  0,026  Pyruvate kinase inhibitor
0,380  0,039  Cytotoxic
0,348  0,008  Antineoplastic (bone cancer)
0,341  0,002  DOPA decarboxylase inhibitor
0,345  0,008  NADPH oxidase inhibitor
0,345  0,010  Neurotrophic factor enhancer
0,396  0,065  Immunosuppressant
0,382  0,052  Streptokinase A inhibitor
0,332  0,004  Gastritis treatment
0,340  0,015  Tubulin antagonist
0,345  0,023  Antihelmintic
0,325  0,005  Histidine decarboxylase inhibitor
0,407  0,087  Cyclophilin D inhibitor
0,407  0,087  Antidiabetic
0,346  0,035  Antineoplastic (liver cancer)
0,340  0,032  Antiulcerative
0,402  0,094  Alzheimer's disease treatment
0,361  0,057  Antifungal
0,340  0,038  Myocardial infarction treatment
0,342  0,040  Tumour necrosis factor alpha release inhibitor
0,320  0,020  DNA methyltransferase I inhibitor
0,327  0,032  Antineoplastic enhancer
0,318  0,026  Dual specificity phosphatase inhibitor
0,319  0,028  Platelet adhesion inhibitor
0,292  0,003  SULT1E1 substrate
0,293  0,005  Aromatase inhibitor
0,289  0,003  Fatty acid synthase inhibitor
0,353  0,070  Angiogenesis inhibitor
0,296  0,014  Acetylcholinesterase inhibitor
0,305  0,025  UGT2B7 substrate
0,322  0,049  Antipyretic
0,281  0,008  Dementia treatment
0,293  0,023  Antineoplastic (carcinoma)
0,320  0,050  DNA damaging
0,275  0,008  Vascular dementia treatment
0,306  0,041  Antineoplastic (bladder cancer)
0,276  0,013  Chelator
0,271  0,007  Estrogen antagonist
0,268  0,008  VEGF expression inhibitor
0,308  0,048  Antineoplastic (lymphoma)
0,265  0,006  Estrogen receptor beta antagonist
0,340  0,086  Prostaglandin dehydrogenase inhibitor
0,263  0,013  Cystathionine beta-synthase inhibitor
0,283  0,033  DNA methylase inhibitor
0,275  0,032  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,259  0,017  LDLR expression enhancer
0,247  0,007  CF transmembrane conductance regulator agonist
0,338  0,098  Antiprotozoal
0,264  0,026  Carcinogenic, group 3
0,292  0,054  Cardiovascular analeptic
0,243  0,005  Interleukin 5 antagonist
0,265  0,027  Amyloid beta precursor protein antagonist
0,298  0,061  Huntington's disease treatment
0,276  0,040  Abortion inducer
0,239  0,006  Postmenopausal disorders treatment
0,229  0,004  Xanthine dehydrogenase inhibitor
0,234  0,010  Carbonic anhydrase XIII inhibitor
0,253  0,029  Antineoplastic (gastric cancer)
0,243  0,019  Antiprotozoal (Coccidial)
0,299  0,076  Analeptic
0,220  0,007  Antineoplastic (uterine cancer)
0,271  0,061  Angiogenesis stimulant
0,233  0,024  Cyclooxygenase 1 inhibitor
0,212  0,005  Lipase inhibitor
0,233  0,028  Phospholipase A2 inhibitor
0,220  0,018  Interleukin 4 antagonist
0,233  0,033  Cholinergic
0,226  0,028  UGT2B9 substrate
0,239  0,041  Insulin sensitizer
0,204  0,008  Estrogen agonist
0,220  0,024  UGT2B10 substrate
0,216  0,023  Topoisomerase I inhibitor
0,212  0,019  Farnesoid X receptor antagonist
0,287  0,098  Antithrombotic
0,252  0,066  Antineoplastic (lymphocytic leukemia)
0,266  0,082  Lipoprotein disorders treatment
0,218  0,036  Succinate dehydrogenase inhibitor
0,231  0,050  Pneumotoxic
0,216  0,036  Antiviral (Influenza A)
0,234  0,056  Antiviral (West Nile virus)
0,199  0,021  Carcinogenic, group 2B
0,185  0,010  Electron transport complex I inhibitor
0,245  0,073  Antineoplastic (sarcoma)
0,183  0,011  NAD(P)H dehydrogenase (quinone) inhibitor
0,190  0,019  Coagulant
0,181  0,015  Multidrug resistance-associated protein 1 inhibitor
0,188  0,023  Antineoplastic antibiotic
0,274  0,109  Antineoplastic (small cell lung cancer)
0,253  0,094  GST M1-1 substrate
0,177  0,019  Photosensitizer
0,181  0,023  SULT1A1 substrate
0,219  0,063  Antiviral (Influenza)
0,161  0,005  Neuraminidase inhibitor
0,170  0,015  Urease inhibitor
0,225  0,072  Interleukin antagonist
0,165  0,012  Macrophage migration inhibitory factor inhibitor
0,179  0,026  Antihelmintic (Trematoda)
0,188  0,036  SULT1A3 substrate
0,162  0,011  Antiviral (Coronavirus)
0,162  0,011  Antiviral (SARS coronavirus)
0,190  0,040  Antiseptic
0,222  0,072  Antimitotic
0,176  0,027  MAP kinase kinase 4 inhibitor
0,183  0,034  DNA polymerase I inhibitor
0,197  0,048  Antiviral (Herpes)
0,160  0,012  HIV-1 integrase (3'-Processing) inhibitor
0,157  0,010  Aldose reductase inhibitor
0,252  0,107  Antimycobacterial
0,178  0,035  Toll-Like receptor 2 antagonist
0,182  0,039  Antifungal enhancer
0,170  0,028  Butyrylcholinesterase inhibitor
0,164  0,030  Expectorant
0,160  0,028  Choleretic
0,167  0,037  Cholesterol synthesis inhibitor
0,138  0,008  Phosphodiesterase VI inhibitor
0,155  0,025  AMP-activated protein kinase stimulant
0,179  0,051  Cyclooxygenase inhibitor
0,133  0,007  Estradiol 17 beta-dehydrogenase inhibitor
0,137  0,014  HIV-1 integrase (Strand Transfer) inhibitor
0,160  0,037  Gout treatment
0,141  0,019  UGT2B11 substrate
0,173  0,053  Protein kinase stimulant
0,129  0,010  Neuraminidase (influenza) inhibitor
0,153  0,038  Interleukin 1b antagonist
0,212  0,099  Antidiabetic symptomatic
0,125  0,012  Alpha tubulin antagonist
0,137  0,025  Alcohol dehydrogenase inhibitor
0,115  0,004  Transcription factor RelA inhibitor
0,120  0,009  Estrogen receptor beta agonist
0,143  0,034  HDL-cholesterol increasing
0,119  0,011  Ca(v)3.1 blocker
0,288  0,179  5 Hydroxytryptamine release inhibitor
0,124  0,016  Beta tubulin antagonist
0,119  0,011  CDC25B inhibitor
0,128  0,021  Ornithine decarboxylase inhibitor
0,125  0,018  CDC25A inhibitor
0,221  0,114  Antidiabetic (type 2)
0,119  0,017  Leukotriene synthesis inhibitor
0,198  0,098  Antiglaucomic
0,140  0,043  Contraceptive female
0,122  0,026  Telomerase inhibitor
0,161  0,065  Interferon gamma antagonist
0,142  0,047  Beta amyloid protein antagonist
0,190  0,096  Cardiodepressant
0,272  0,178  DNA directed DNA polymerase inhibitor
0,115  0,021  Peroxisome proliferator-activated receptor gamma agonist
0,102  0,008  Estrogen receptor alpha agonist
0,190  0,096  Antialcoholic
0,125  0,035  Uric acid excretion stimulant
0,144  0,055  M18 aspartyl aminopeptidase inhibitor
0,119  0,031  ABCA1 expression enhancer
0,188  0,101  Teratogen
0,161  0,076  Arachidonic acid antagonist
0,157  0,074  Peroxidase inhibitor
0,105  0,022  HIV-1 integrase inhibitor
0,207  0,125  Transcription factor STAT3 inhibitor
0,165  0,084  Dual specificity phosphatase 3 inhibitor
0,106  0,026  Na+ K+ transporting ATPase inhibitor
0,127  0,054  Alcohol dehydrogenase substrate
0,084  0,011  Potassium channel Kv1.3 blocker
0,106  0,034  Phosphodiesterase 4D inhibitor
0,125  0,053  TRPA1 agonist
0,258  0,187  DNA polymerase beta inhibitor
0,124  0,053  Endometrios treatment
0,193  0,124  Immunostimulant
0,229  0,161  Antiprotozoal (Plasmodium)
0,179  0,111  Hypolipemic
0,117  0,050  Antiinfertility, female
0,069  0,004  Estrogen-related receptor beta antagonist
0,201  0,137  Transcription factor STAT inhibitor
0,093  0,030  SULT1A2 substrate
0,116  0,052  UGT2B1 substrate
0,119  0,057  Aldehyde dehydrogenase substrate
0,156  0,094  Death-associated protein kinase 2 inhibitor
0,122  0,064  Antiviral (Influenza B)
0,092  0,036  Keratolytic
0,165  0,109  Embryotoxic
0,114  0,060  Mucolytic
0,100  0,050  Bile acid receptor antagonist
0,093  0,044  Myeloperoxidase inhibitor
0,081  0,032  Peroxisome proliferator-activated receptor gamma antagonist
0,123  0,076  Cyclooxygenase 2 inhibitor
0,267  0,220  Antineoplastic (solid tumors)
0,063  0,016  Cathepsin L2 inhibitor
0,155  0,108  Non-steroidal antiinflammatory agent
0,124  0,078  Vanilloid 1 agonist
0,144  0,098  Male reproductive disfunction treatment
0,065  0,019  Glucose-6-phosphate translocase inhibitor
0,128  0,083  Psychosexual dysfunction treatment
0,088  0,043  Thioredoxin reductase inhibitor
0,051  0,007  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,086  0,042  Antibiotic
0,120  0,077  Cyclooxygenase 3 inhibitor
0,208  0,165  Thioredoxin glutathione reductase inhibitor
0,067  0,025  Postcoital contraceptive
0,104  0,063  Toll-Like receptor 4 antagonist
0,053  0,013  Inosine monophosphate dehydrogenase inhibitor
0,095  0,055  Thioredoxin inhibitor
0,104  0,066  Mediator release inhibitor
0,046  0,010  Catechol O-methyltransferase inhibitor
0,057  0,021  Carbonic anhydrase VII inhibitor
0,123  0,088  Histone deacetylase SIRT1 inhibitor
0,145  0,110  Cyclin-dependent kinase 3 inhibitor
0,061  0,026  Peroxisome proliferator-activated receptor alpha agonist
0,056  0,022  Factor III inhibitor
0,102  0,071  Skin irritative effect
0,066  0,036  Transcription factor AP-1 inhibitor
0,096  0,066  Carbonic anhydrase III inhibitor
0,157  0,129  Histone acetyltransferase inhibitor
0,040  0,013  Cholesterol ester transfer protein antagonist
0,127  0,100  Hemostatic
0,057  0,031  Leukotriene B4 antagonist
0,044  0,019  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,117  0,093  Antiprotozoal (Trichomonas)
0,172  0,148  Nitric-oxide synthase stimulant
0,126  0,103  Thrombolytic
0,096  0,073  Carbonic anhydrase XV inhibitor
0,105  0,082  Microtubule formation inhibitor
0,174  0,152  Antituberculosic
0,071  0,050  Phosphodiesterase V inhibitor
0,127  0,106  Antifungal (Cryptococcus)
0,053  0,034  Vanilloid 2 antagonist
0,082  0,064  3C-Like protease (SARS coronavirus) inhibitor
0,027  0,009  Inosine monophosphate dehydrogenase 2 inhibitor
0,091  0,076  Glutathione S-transferase substrate
0,067  0,053  Phosphodiesterase 5A inhibitor
0,125  0,112  Hexokinase inhibitor
0,068  0,056  Cathepsin G inhibitor
0,056  0,045  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,087  0,076  Creatine kinase inhibitor
0,073  0,062  Antitreponemal
0,140  0,129  Phospholipase C inhibitor
0,082  0,072  ATPase (Vacuolar H+) inhibitor
0,038  0,029  Retinoic acid alpha receptor agonist
0,057  0,049  Bcl-xL inhibitor
0,055  0,046  Prostaglandin EP2 antagonist
0,127  0,119  Aldose reductase substrate
0,079  0,073  Vanilloid agonist
0,020  0,014  Inosine monophosphate dehydrogenase 1 inhibitor
0,040  0,035  DNA gyrase subunit A inhibitor
0,118  0,114  Insulin secretagoues
0,024  0,023  Leukotriene B4 receptor 1 antagonist

